Company Filing History:
Years Active: 2011
Title: Innovative Breakthroughs by Yoshiki Tanaka
Introduction
Yoshiki Tanaka, an accomplished inventor based in Hanno, Japan, has made significant contributions to the field of pharmaceutical innovations. With a focus on compounds that can inhibit prostaglandin D synthetase, Tanaka's work has implications for various diseases including allergic and inflammatory conditions, as well as Alzheimer's disease.
Latest Patents
Tanaka holds a patent for a benzoimidazole compound capable of inhibiting prostaglandin D synthetase. This invention is represented by a formula where X can be either oxygen or carbonyl, and R is either a furan ring with 1 to 3 substituents or a pyrrole ring that may also have 1 to 3 substituents. The patent explicitly excludes compounds where at least one substituent is a phosphoric acid or phosphoric ester group. The compound or its salt demonstrates excellent activity in inhibiting prostaglandin synthase, proving useful in the prevention and treatment of diseases where prostaglandin D2 plays a role, such as allergies, inflammation, and Alzheimer's disease.
Career Highlights
Yoshiki Tanaka is currently affiliated with Taiho Pharmaceutical Company Limited, a notable institution in the pharmaceutical sector. His research is pivotal in developing therapeutic agents that address severe health concerns through innovative chemical compounds and treatments.
Collaborations
In his pursuit of innovation, Tanaka collaborates with esteemed colleagues, including Yoshihiro Urade and Keiko Yamane. Together, they contribute to the advancement of pharmaceutical research, enhancing the potential for discovering effective therapies.
Conclusion
Yoshiki Tanaka's innovative contributions to the field of pharmaceuticals underscore the importance of inventive minds in discovering new solutions to complex health challenges. His patented benzoimidazole compound exemplifies how targeted research can yield significant advancements in medicine, ultimately benefiting society through improved treatment options.